跳至主要内容
临床试验/ACTRN12605000611628
ACTRN12605000611628已完成3 期

DOES USE OF INHALED FLUTICASONE PRIOR TO AN ADENOSINE 5'MONOPHOSPHATE (AMP) BRONCHIAL PROVOCATION TEST AFFECT THE PERCEPTION OF DYSPNOEA in asthmatic patients and the development of nasal symptoms?

Woolcock Institute of Medical Research0 个研究点目标入组 12 人开始时间: 2005年10月6日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
12

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Diagnosis
盲法
Blinded (masking used)

入排标准

年龄范围
ot stated 至 ot stated(—)
性别
All

入选标准

  • Allergy to inhaled allergens. Mild asthma and rhinitis.

排除标准

  • No exclusion criteria

研究者

相似试验

尚未招募
3 期
Early inhaled fluticasone use for the prevention of bronchopulmonary dysplasia in premature infantsPreterm infants who receive inhaled corticosteroid may have adverse clinical symptoms such as hyperglycemic episodes requiring insulin treatment, hypertensive episodes requiring antihypertensive treatment.Inhaled corticosteroidsPreterm infantPreventionBronchopulmonary dysplasia
TCTR20210929009Faculty of Medicine, Prince of Songkla University146
尚未招募
不适用
Comparison of fluticasone/vilanterol vs fluticasone/salmeterol in stable copd patients
CTRI/2022/02/039895SRM college of pharmacy
进行中(未招募)
不适用
A 6-month study to assess the safety and benefit of inhaled fluticasone propionate/salmeterol combination compared with inhaled fluticasone propionate in the treatment of adolescents (12 years and over) and adults with asthma.AsthmaMedDRA version: 17.1Level: PTClassification code 10003553Term: AsthmaSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders
EUCTR2011-001644-29-CZGlaxoSmithKline Research & Development Limited11,664
进行中(未招募)
不适用
A study of the Effects of Inhaled Fliticasone Furotate/GW642444 versus Placebo on HPA Axis of Adolescent and Adult Asthmatics.Adolescent (12-17 years) and Adult AsthmathicsMedDRA version: 12.1Level: LLTClassification code 10003553Term: Asthma
EUCTR2009-017669-44-PLGlaxoSmithKline185
已完成
不适用
Additional effects of moderate-dose fluticasone and salmeterol combination therapy on exacerbations and airflow limitations in patients with COPD in JapaCOPD
JPRN-UMIN000007544Kyusyu Asthma & COPD Forum1,008